← All trials
NCT07032558
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 20, 2025
- Primary completion
- Sep 25, 2025
- Completion date
- Oct 25, 2025
- First posted
- Jun 24, 2025
- Last posted
- Aug 28, 2025
- Enrollment
- 14
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hai Phong Medical UniversityLead sponsor
- Big Leap ResearchCollaborator
- Daewon Pharmaceutical Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.